Trial Profile
Clinical Trials Insight: 700028189
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Sep 2008
Price :
$35
*
At a glance
- Drugs Cixutumumab (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors ImClone Systems
- 24 Jul 2008 Status changed from planned to recruiting as reported by ImClone Systems.
- 06 Nov 2007 New trial record.